Key statistics
On Friday, Mirum Pharmaceuticals Inc (MIRM:NMQ) closed at 38.96, -13.86% below its 52-week high of 45.23, set on Aug 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 39.46 |
---|---|
High | 39.65 |
Low | 38.60 |
Bid | 35.43 |
Offer | 40.00 |
Previous close | 39.35 |
Average volume | 476.82k |
---|---|
Shares outstanding | 47.71m |
Free float | 46.50m |
P/E (TTM) | -- |
Market cap | 1.86bn USD |
EPS (TTM) | -2.40 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
- Mirum Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
- Mirum Pharmaceuticals to Announce Second Quarter 2024 Financial Results and Host Conference Call on August 7, 2024
- Mirum’s LIVMARLI Now Approved for PFIC in Patients 12 Months and Older
- Mirum Pharmaceuticals’ LIVMARLI Approved in the European Union for Patients with PFIC
- Mirum Submits New Drug Application to FDA for Chenodiol for the Treatment of CTX
More ▼